Insider · CIK 0001187159

MILANO VINCENT

Reports to the SEC for 7 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001187159

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+1,159 sh	$9.70	+$11.2K	109,642
2026-06-11	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+33.5K sh	—	—	33,540
2026-06-11	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+15.3K sh	—	—	108,483
2026-06-05	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−11.6K sh	—	—	0
2026-06-05	ACRSAclaris Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+11.6K sh	—	—	28,896
2026-06-04	ACRSAclaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+42.4K sh	—	—	42,350
2026-06-04	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+11K sh	—	—	10,987
2026-05-29	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+1,122 sh	$8.91	+$9,997.02	93,189
2026-02-27	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+848 sh	$8.75	+$7,420	92,067
2025-11-28	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+783 sh	$7.18	+$5,621.94	91,219
2025-08-29	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+676 sh	$8.31	+$5,617.56	90,436
2025-06-12	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+12.5K sh	—	—	89,760
2025-06-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+27.2K sh	—	—	27,181
2025-06-06	ACRSAclaris Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,793 sh	—	—	17,316
2025-06-06	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,793 sh	—	—	0
2025-06-05	ACRSAclaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+42.4K sh	—	—	42,350
2025-06-05	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+11.6K sh	—	—	11,580
2025-05-30	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+523 sh	$10.75	+$5,622.25	77,260
2025-02-28	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+653 sh	$8.61	+$5,622.33	76,737
2024-11-29	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+750 sh	$7.50	+$5,625	76,084
2024-08-30	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+647 sh	$8.69	+$5,622.43	75,334
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+49.9K sh	—	—	49,933
2024-06-12	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+6,820 sh	—	—	74,687
2024-06-06	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+4,793 sh	—	—	4,793
2024-06-06	ACRSAclaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.8K sh	—	—	15,750
2024-06-01	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,660 sh	—	—	0
2024-06-01	ACRSAclaris Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,660 sh	—	—	12,523
2024-05-31	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+870 sh	$6.46	+$5,620.2	67,867
2024-05-20	BCRXBIOCRYST PHARMACEUTICALS INCP Purchase	Director	PPurchase	+15K sh	$6.25	+$93.8K	66,997
2024-02-29	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+999 sh	$5.63	+$5,624.37	51,997
2023-11-30	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+956 sh	$5.88	+$5,621.28	50,998
2023-08-31	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+791 sh	$7.11	+$5,624.01	50,042
2023-08-10	Aceragen, Inc.S Sale	Director	SSale	−3,283 sh	$0.53	−$1,750.167	8,987
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+39.1K sh	—	—	39,072
2023-06-13	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+16.7K sh	—	—	49,251
2023-06-02	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−4,507 sh	—	—	0
2023-06-02	ACRSAclaris Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,507 sh	—	—	7,863
2023-06-01	ACRSAclaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.8K sh	—	—	15,750
2023-06-01	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+4,660 sh	—	—	4,660
2023-05-31	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+680 sh	$8.27	+$5,623.6	32,506
2023-02-28	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+635 sh	$8.85	+$5,619.75	31,826
2022-11-30	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+421 sh	$13.36	+$5,624.56	31,191
2022-08-31	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+404 sh	$13.90	+$5,615.6	30,770
2022-07-06	Aceragen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+124K sh	—	—	124,000
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INC · Automatic Stock Option GrantA Award	Director	AAward	+30K sh	—	—	30,022
2022-06-07	BCRXBIOCRYST PHARMACEUTICALS INCA Award	Director	AAward	+12.9K sh	—	—	30,366
2022-06-03	ACRSAclaris Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,356 sh	—	—	3,356
2022-06-03	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,356 sh	—	—	0
2022-06-02	ACRSAclaris Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15.8K sh	—	—	15,750
2022-06-02	ACRSAclaris Therapeutics, Inc. · Restricted Stock UnitsA Award	Director	AAward	+4,507 sh	—	—	4,507

Recent filings

Accepted (ET)
Sep 24
MILANO VINCENT0000882796-26-000061
SEC(opens sec.gov)
Jun 154
MILANO VINCENT0000882796-26-000041
SEC(opens sec.gov)
Jun 84
MILANO VINCENT0001187159-26-000002
SEC(opens sec.gov)
Jun 24
MILANO VINCENT0000882796-26-000027
SEC(opens sec.gov)
Mar 34
MILANO VINCENT0000882796-26-000009
SEC(opens sec.gov)
Dec 24
MILANO VINCENT0000882796-25-000019
SEC(opens sec.gov)
Sep 34
MILANO VINCENT0000882796-25-000003
SEC(opens sec.gov)
Jun 164
MILANO VINCENT0001171843-25-003917
SEC(opens sec.gov)
Jun 94
MILANO VINCENT0001415889-25-016251
SEC(opens sec.gov)
Jun 34
MILANO VINCENT0001127602-25-016424
SEC(opens sec.gov)
Mar 44
MILANO VINCENT0001127602-25-007884
SEC(opens sec.gov)
Dec 24
MILANO VINCENT0001127602-24-028290
SEC(opens sec.gov)

Companies

Address

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703